MD Anderson Cancer Center partners with biotech co. to improve cancer immunotherapy response

Dr. Jennifer Wargo, director of MD Anderson's Platform for Innovative Microbiome and Translational Research, said the partnership with Federation Bio is significant because of difficulties performing fecal transplant.

Seattle-area home sales stay cool amid high interest rates, low inventory

Peek inside JPMorgan’s new downtown Seattle tech center

5 tax credits every business owner should know about

2023 Executives of the Year: Braden McCurdy, McCurdy Real Estate & Auction LLC

Historic Georgetown mansion to hit market for $18.75 million

C.H. Robinson opens new cross-border trucking facility in Laredo, Texas

Wells Fargo’s national woes aren’t slowing it down in Tampa Bay

Patti Payne’s Cool Pads: Normandy Park showstopper estate lists for $6.25M

MD Anderson Cancer Center partners with biotech co. to improve cancer immunotherapy response

Previous FCA Venture Partners, Nashville-based health tech venture firm, closes $71 million fund

Next A downtown People's Park restaurant more than 10 years in making

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Hudson Pacific drops 2 Santa Monica office properties

Atlanta Mayor: Stalled Microsoft campus already had ‘economic consequences’ on Westside

Snapshot: Tampa Bay area public companies’ fiscal results

After Comerica’s notice of default, North Carolina public company MobileSmith files for bankruptcy

Amid U.S. apartment boom, luxury Midtown high rise prepares to open (Renderings)

5 things to know today, including why I’m already thinking about Christmas

MENU

FirstStar Group

More Stories

McKinney’s Independent Bank buys Denver bank in $1B deal